介入放射学杂志
介入放射學雜誌
개입방사학잡지
JOURNAL OF INTERVENTIONAL RADIOLOGY
2015年
4期
311-313
,共3页
王玉林%胡荣奎%贾中芝%田丰%蒋国民
王玉林%鬍榮奎%賈中芝%田豐%蔣國民
왕옥림%호영규%가중지%전봉%장국민
膀胱癌%血尿%栓塞
膀胱癌%血尿%栓塞
방광암%혈뇨%전새
bladder cancer%hematuria%embolization
目的探讨动脉内栓塞(TAE)治疗晚期膀胱癌的临床疗效。方法回顾性分析22例行TAE治疗的晚期膀胱癌患者的临床及影像资料,总结TAE治疗晚期膀胱癌的临床疗效。结果本组22例患者均成功行TAE治疗,手术成功率100%。22例患者中,术前与术后1个月腹痛评分分别为4.73±1.91和2.45±1.29(P<0.01),ECOG体能评分分别为3.14±0.47和2.68±0.56(P<0.05),血红蛋白分别为(61.4±11.8)和(79.3±14.5)g/L(P<0.01)。7例存在尿路梗阻患者中,5例尿路梗阻消失,2例梗阻症状减轻,但仍有排尿不畅。随访(7.1±3.0)(1.5~24)个月,半年生存率为54.5%(12/22)。无严重并发症发生。结论 TAE不但有效改善因肿瘤导致的血尿和尿路梗阻症状,而且还可以有效控制肿瘤生长、改善患者生活质量、延长生存期。
目的探討動脈內栓塞(TAE)治療晚期膀胱癌的臨床療效。方法迴顧性分析22例行TAE治療的晚期膀胱癌患者的臨床及影像資料,總結TAE治療晚期膀胱癌的臨床療效。結果本組22例患者均成功行TAE治療,手術成功率100%。22例患者中,術前與術後1箇月腹痛評分分彆為4.73±1.91和2.45±1.29(P<0.01),ECOG體能評分分彆為3.14±0.47和2.68±0.56(P<0.05),血紅蛋白分彆為(61.4±11.8)和(79.3±14.5)g/L(P<0.01)。7例存在尿路梗阻患者中,5例尿路梗阻消失,2例梗阻癥狀減輕,但仍有排尿不暢。隨訪(7.1±3.0)(1.5~24)箇月,半年生存率為54.5%(12/22)。無嚴重併髮癥髮生。結論 TAE不但有效改善因腫瘤導緻的血尿和尿路梗阻癥狀,而且還可以有效控製腫瘤生長、改善患者生活質量、延長生存期。
목적탐토동맥내전새(TAE)치료만기방광암적림상료효。방법회고성분석22례행TAE치료적만기방광암환자적림상급영상자료,총결TAE치료만기방광암적림상료효。결과본조22례환자균성공행TAE치료,수술성공솔100%。22례환자중,술전여술후1개월복통평분분별위4.73±1.91화2.45±1.29(P<0.01),ECOG체능평분분별위3.14±0.47화2.68±0.56(P<0.05),혈홍단백분별위(61.4±11.8)화(79.3±14.5)g/L(P<0.01)。7례존재뇨로경조환자중,5례뇨로경조소실,2례경조증상감경,단잉유배뇨불창。수방(7.1±3.0)(1.5~24)개월,반년생존솔위54.5%(12/22)。무엄중병발증발생。결론 TAE불단유효개선인종류도치적혈뇨화뇨로경조증상,이차환가이유효공제종류생장、개선환자생활질량、연장생존기。
Objective To investigate the therapeutic efficacy of transcatheter arterial embolization (TAE) in treating advanced bladder cancer. Methods A total of 22 patients with advanced bladder cancer were included in this study. The clinical data and the imaging materials were retrospectively analyzed. The clinical efficacy of TAE in treating advanced bladder cancer was evaluated. Results TAE was successfully accomplished in all the 22 patients. The preoperative and the postoperative abdominal pain scores were 4.73± 1.91 and 2.45±1.29 respectively, the difference was statistically significant (P<0.01); the preoperative and the postoperative ECOG scores were 3.14±0.47 and 2.68±0.56 respectively (P<0.05); the preoperative and the postoperative hemoglobin levels were (61.4±11.8) g/L and (79.3±14.5) g/L respectively (P<0.01). Of 7 patients with urinary tract obstruction, after the treatment the obstruction disappeared in 5 and was improved in 2, although the urination was still not smooth. All patients were followed up for (7.1±3.0) months. The 6-month survival rate was 54.5% (12/22). No serious complications occurred in all patients. Conclusion TAE can not only effectively improve the hematuria and urinary tract obstruction symptoms caused by bladder cancer, but also effectively control the tumor growth, improve the quality of life and prolong the survival time as well.